FDA orders stronger fungal warnings
Thursday, September 4, 2008 - 11:35
in Health & Medicine
WASHINGTON, Sept. 4 (UPI) -- The U.S. Food and Drug Administration says manufacturers of Humira, Cimzia, Enbrel and Remicade must emphasize the risk of developing fungal infections.